Rethinking Cancer Vaccine Carriers: A Bottleneck-First Test of Antigen Delivery Platforms
A new review in Materials Today Bio proposes a bottleneck-first framework for evaluating antigen delivery platforms in therapeutic cancer vaccines, ...
A new review in Materials Today Bio proposes a bottleneck-first framework for evaluating antigen delivery platforms in therapeutic cancer vaccines, ...
A new review details how nanoparticles disguised with red blood cell membranes, exosomes, and synthetic coatings, loaded with personalized neoantigens, ...
Vanderbilt scientist Dr. Annet Kirabo, whose research revealed how immune activation and inflammation drive hypertension, will receive the American Heart ...
A new review charts how mRNA, peptide, cell, and virus-based therapeutic vaccines, supercharged by AI-driven neoantigen prediction and combination immunotherapy, ...
A new review details how mRNA therapeutics are expanding beyond infectious disease vaccines into cancer immunotherapy, protein replacement, autoimmune tolerance, ...
A selective dual T-cell activator directed at the TCR beta chain revives exhausted antitumor T cells and sensitizes checkpoint-resistant cancers ...
A new Perspective argues that next-generation oncolytic viruses act as antigen-agnostic in situ vaccines capable of priming de novo antitumor ...
In recent developments in the field of oncology, researchers in the United Kingdom have taken a groundbreaking step by articulating ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine